PHARMAKES
ActiveSummary
PHARMAKES has been active since 2012 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €1.2m and a net result of €32,749. Equity is growing by about 23% per year across the filed financial years. Its solvency ranks better than 80% of 12,724 sector peers (NACE 47, financial year 2025). The computed 12-month bankruptcy probability is 1.0% (low).
Directors
Directors
1 director, last change in 2023
Roel KESTELYN
CurrentDirector · since 01-12-2023
Derived from published Gazette deeds. The KBO keeps the official list of office holders; we do not read it, so the two can differ.
See the directors and other office holders in the KBO →
Not every act has been read: a resignation may still be missing
3 of this company's 5 Belgian Official Gazette deeds have not been read yet. Appointments and resignations recorded in them are not yet in the list of directors: someone who resigned there may still be listed as sitting. The acts are in the Timeline.
Mandate history
1 person since 2023, 1 in office
- Board
| Name | Functions and periods |
|---|---|
| Roel KESTELYN |
|
Owners and capital
Capital and shareholders
Capital over the years
- 01-12-2023 Capital stated in the deed · 1,000 shares